Genes and osteoporosis – editorial

Czech version

Authors: V. Palička
Authors‘ workplace: Osteocentrum, Ústav klinické biochemie a diagnostiky LF UK a FN Hradec Králové, přednosta prof. MU Dr. Vladimír Palička, CSc., dr. h. c.
Published in: Vnitř Lék 2011; 57(1): 27-28
Category: Editorials

Sources

1. Chmelařová M, Palička V. Hypermetylace DNA u ovariálního karcinomu. Klin Biochem Metab 2010; 18 : 214 –⁠ 218.

2. David V, Quarles LD. ASARM Mineralization Hypothesis: A Bridge Too Far? J Bone Miner Res 2010; 25 : 692 –⁠ 694.

3. Duncan EL, Brown MA. Genetic Determinants of Bone Density and Fracture Risk –⁠ State of the Art and Future Directions. J Clin Endocrinol Metab 2010; 95 : 2576 –⁠ 2587.

4. Earl SC, Harvey N, Cooper C. The Epigenetic Regulation of Bone Mass. IBMS BoneKEy 2010; 7 : 54 –⁠ 62.

5. Ferrari S. Human genetics of osteoporosis. Best Pract Res Clin Endocr Metab 2008; 22 : 723 –⁠ 735.

6. Kato S, Inoue K, Youn MY. Emergence of the Osteo ‑⁠ Epigenome in Bone Biology. IBMS BoneKEy 2010; 7, 314 –⁠ 324.

7. Marini F, Falchetti A, Silvestri S et al. Modulatory effect of farnesyl pyropshosphate synthase (FDPS) rs2297480 polymorphism on the response to long‑term amino ‑⁠ bisphosphonate treatment in postmenopausal osteoporosis. Curr Med Res Opin 2008; 24 : 2609 –⁠ 2615.

8. Reppe S, Refvem H, Gautvik VT et al. Eight genes are highly associated with BMD variation in postmenopausal Caucasian women. Bone 2010; 46 : 604 –⁠ 612.

9. Zhang YP, Deng FY, Chen Y et al. Replication study of candidate genes/ loci associated with osteoporosis based on genome ‑⁠ wide screening. Osteoporosis Int 2010; 21 : 785 –⁠ 795.